EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis

Felix Immanuel Maier, David Klinger, Mark Grieshober, Reiner Noschka, Armando Rodriguez, Sebastian Wiese, Wolf-Georg Forssmann, Ludger Ständker, Steffen Stenger

Medical Microbiology and Immunology · 2024-12 · 213 (1)

DOI: 10.1007/s00430-024-00793-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Microbiology and Immunology, online erschienen am 20.06.2024. Verfasst von Felix Immanuel Maier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology and Infection and Hygiene, Ulm University, Ulm, Germany. Hauptthemen laut MEDLINE: Muramidase, Mycobacterium tuberculosis, Macrophages. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität Ulm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endogenous antimicrobial peptides (AMPs) play a key role in the host defense against pathogens. AMPs attack pathogens preferentially at the site of entry to prevent invasive infection. Mycobacterium tuberculosis ( Mtb ) enters its host via the airways. AMPs released into the airways are therefore likely candidates to contribute to the clearance of Mtb immediately after infection. Since lysozyme is detectable in airway secretions, we evaluated its antimicrobial activity against Mtb . We demonstrate that lysozyme inhibits the growth of extracellular Mtb , including isoniazid-resistant strains. Lysozyme also inhibited the growth of non-tuberculous mycobacteria. Even though lysozyme entered Mtb -infected human macrophages and co-localized with the pathogen we did not observe antimicrobial activity. This observation was unlikely related to the large size of lysozyme (14.74 kDa) because a smaller lysozyme-derived peptide also co-localized with Mtb without affecting the viability. To evaluate whether the activity of lysozyme against extracellular Mtb could be relevant in vivo, we incubated Mtb with fractions of human serum and screened for antimicrobial activity. After several rounds of sub-fractionation, we identified a highly active fraction-component as lysozyme by mass spectrometry. In summary, our results identify lysozyme as an antimycobacterial protein that is detectable as an active compound in human serum. Our results demonstrate that the activity of AMPs against extracellular bacilli does not predict efficacy against intracellular pathogens despite co-localization within the macrophage. Ongoing experiments are designed to unravel peptide modifications that occur in the intracellular space and interfere with the deleterious activity of lysozyme in the extracellular environment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MuramidaseMycobacterium tuberculosisMacrophagesHumansAntimicrobial PeptidesMicrobial Sensitivity TestsMicrobial Viability

Stichwörter der Autor:innen

Antimicrobial peptidesHumanLysozymeMacrophagesTuberculosis

Substanzen

MuramidaseAntimicrobial Peptides

Autor:innen und Institutionen

  • Institute of Medical Microbiology and Infection and Hygiene, Ulm University, Ulm, Germany.
  • Core Facility of Functional Peptidomics, Ulm University, Meyerhoferstraße 4, 89081, Ulm, Germany.
  • Core Unit Mass Spectrometry and Proteomics, Ulm University, Albert Einstein Allee 23, 89081, Ulm, Germany.
  • Pharis Biotec GmbH, Feodor-Lynen. Str. 31, 30625, Hannover, Germany.
  • Institute of Medical Microbiology and Infection and Hygiene, Ulm University, Ulm, Germany. steffen.stenger@uniklinik-ulm.de.

Förderung

  • Universität Ulm

Zitieren

APA

Maier, F. I., Klinger, D., Grieshober, M., Noschka, R., Rodriguez, A., Wiese, S., Forssmann, W. G., Ständker, L., & Stenger, S. (2024). Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis. Medical Microbiology and Immunology, 213(1). https://doi.org/10.1007/s00430-024-00793-0

Vancouver

Maier FI, Klinger D, Grieshober M, Noschka R, Rodriguez A, Wiese S, et al. Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis. Medical Microbiology and Immunology. 2024;213(1). doi:10.1007/s00430-024-00793-0

BibTeX
@article{Maier2024,
  author = {Maier, Felix Immanuel and Klinger, David and Grieshober, Mark and Noschka, Reiner and Rodriguez, Armando and Wiese, Sebastian and Forssmann, Wolf-Georg and Ständker, Ludger and Stenger, Steffen},
  title = {Lysozyme: an endogenous antimicrobial protein with potent activity against extracellular, but not intracellular Mycobacterium tuberculosis},
  journal = {Medical Microbiology and Immunology},
  year = {2024},
  volume = {213},
  number = {1},
  doi = {10.1007/s00430-024-00793-0}
}
Kostenlos starten →